← FDA Drug Approvals (Drugs@FDA)
NALBUPHINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ABRAXIS PHARM · Approved 1986-07-02
Drug application
- FDA Application #
ANDA070751- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NALBUPHINE
- Generic name
- Nalbuphine Hydrochloride
- Active ingredients
- NALBUPHINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- ABRAXIS PHARM
- First approval
- 1986-07-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown